Eli Lilly taps former US FDA official Peter Marks to head infectious disease

Investing.comWednesday, October 8, 2025 at 9:19:17 AM
Eli Lilly taps former US FDA official Peter Marks to head infectious disease
Eli Lilly has appointed Peter Marks, a former official from the US FDA, to lead its infectious disease division. This move is significant as Marks brings extensive experience in regulatory affairs and public health, which could enhance the company's efforts in developing treatments for infectious diseases. His leadership is expected to drive innovation and improve patient outcomes, making this a promising development for both Eli Lilly and the healthcare sector.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugs
NeutralFinancial Markets
Robert F. Kennedy Jr., the health secretary, is navigating a complex landscape regarding obesity drugs, which are becoming a pivotal issue in his relationship with both supporters and President Trump. During a meeting in the Oval Office on November 6, Kennedy engaged with health officials and executives from major pharmaceutical companies like Novo Nordisk and Eli Lilly, highlighting the significance of these weight loss medications in current health policy discussions.